Recent progress in gemcitabine-loaded nanoparticles for pancreatic cancer therapy: a review

吉西他滨 胰腺癌 医学 癌症治疗 癌症 肿瘤科 内科学
作者
Zhaokai Li,Ruijie Shu,Meichai Li,Xinyv Wang,Xinmei Chen,Hang Chen,Xin Wu,Jianping Chen
出处
期刊:Nanoscale [Royal Society of Chemistry]
卷期号:17 (30): 17480-17507 被引量:6
标识
DOI:10.1039/d5nr02005k
摘要

The treatment of pancreatic cancer remains a formidable challenge. Despite recent advances in diagnostic techniques and therapeutic approaches, the overall five-year survival rate for patients with pancreatic cancer remains below 9%, reflecting a dismal prognosis. Currently, surgical resection is the only potentially curative option; however, only about 10% of patients are eligible for surgery at the time of diagnosis. For those with unresectable locally advanced or metastatic pancreatic cancer, chemotherapy remains the mainstay of treatment. In this context, gemcitabine (GEM), a conventional chemotherapeutic agent, holds significant clinical value due to its potent anti-pancreatic cancer activity. Nevertheless, its clinical application has long been hampered by limitations such as a short half-life, rapid metabolic degradation, poor tumor tissue penetration, and dose-dependent toxicity. Although conventional GEM-based nanoformulations have partially improved its pharmacokinetic properties, their therapeutic efficacy and safety still require further enhancement. In recent years, researchers have focused on developing novel nanodelivery systems aimed at overcoming the clinical limitations of GEM through innovative carrier designs and advanced delivery strategies. This review briefly introduces the mechanisms underlying gemcitabine resistance and systematically highlights recent advances in emerging nanoparticles loaded with GEM. Particular attention is given to functional nanocarriers for GEM monotherapy, self-assembled GEM prodrug nanostructures, and GEM-based combinational nanotherapies. Finally, this review discusses the current challenges and future opportunities for the clinical translation of these emerging nanoplatforms.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yan发布了新的文献求助10
1秒前
瞿冷发布了新的文献求助10
1秒前
隐形曼青的应助被莘莘学子采纳,获得10
1秒前
我是老大的应助被小羊肖恩采纳,获得10
1秒前
3秒前
Larmes发布了新的文献求助10
3秒前
陈杰完成签到,获得积分10
3秒前
香蕉觅云的应助被飘逸的语海采纳,获得30
3秒前
tc鱼完成签到,获得积分10
3秒前
3秒前
4秒前
lee发布了新的文献求助10
4秒前
要减肥完成签到,获得积分10
5秒前
万能图书馆的应助被smile采纳,获得10
5秒前
6秒前
天真依白发布了新的文献求助10
6秒前
行者无疆完成签到,获得积分10
6秒前
Luccvy完成签到,获得积分10
6秒前
7秒前
你香发布了新的文献求助10
7秒前
7秒前
beforethedawn完成签到,获得积分10
12秒前
zdk发布了新的文献求助10
12秒前
CipherSage的应助被春风失意采纳,获得10
13秒前
浪浪发布了新的文献求助10
13秒前
名不显时心不朽完成签到,获得积分10
14秒前
ding的应助被ifast采纳,获得10
14秒前
路人乙酸完成签到,获得积分10
15秒前
15秒前
15秒前
17秒前
基尔霍夫完成签到,获得积分10
17秒前
tyche完成签到,获得积分10
17秒前
在水一方的应助被Akirus采纳,获得20
17秒前
瞿冷完成签到,获得积分10
19秒前
科研乐子人完成签到,获得积分10
19秒前
20秒前
21秒前
贾文浩发布了新的文献求助10
21秒前
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8168144
求助须知:如何正确求助?哪些是违规求助? 9561199
关于积分的说明 21759542
捐赠科研通 7759434
什么是DOI,文献DOI怎么找? 3429948
关于科研通互助平台的介绍 2553742
邀请新用户注册赠送积分活动 2474463